T
Alaunos Therapeutics D
D
TCRT
3.19600
USD
0.15
(4.79%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
5,239,909
الأخبار المقالات
العنوان: Alaunos Therapeutics Inc.
القطاع: Healthcare
الصناعة: Biotechnology
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.